-
-
-
-
-
-
-
Fractyl Health, Inc. (GUTS) Tops Q1 EPS by 19c
-
-
-
-
-
-
-
Fractyl Health reports weight maintenance data from Revita procedure study
-
-
-
-
-
-
-
Fractyl Health Inc (GUTS) PT Lowered to $6 at Canaccord Genuity
-
-
-
-
-
-
-
Fractyl Health (GUTS) Advances Rejuva Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
-
-
446,788 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

